# Olmesartan medoxomil

## Olmetec 40mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OOLM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 適應症     | Hypertension: Treatment of hypertension with or without concurrent use of other antihypertensive agents                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量   | Dosing: Adult Hypertension: Oral: Initial: 20 mg once daily; if initial response is inadequate, may be increased to 40 mg once daily after 2 weeks. Usual dosage range: 20 to 40 mg daily. May administer with other antihypertensive agents if blood pressure inadequately controlled with olmesartan. Consider lower starting dose in patients with possible depletion of intravascular volume (eg, patients receiving diuretics). Dosing: Pediatric Hypertension: Children 6 to 16 years: Oral: 20 kg to <35 kg: Initial: 10 mg once daily; if initial response inadequate after 2 weeks, dose may be increased (maximum: 20 mg once daily) >=35 kg: Initial: 20 mg once daily; if initial response inadequate after 2 weeks, dose may be increased (maximum: 40 mg once daily) |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 禁忌       | Concomitant use with aliskiren in patients with diabetes mellitus Canadian labeling: Additional contraindications (not in U.S. labeling): Hypersensitivity to olmesartan or any component of the formulation; concomitant use with aliskiren in patients with moderate to severe renal impairment (GFR <60 mL/minute/1.73 m2)                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 副作用     | 1% to 10%: Central nervous system: Dizziness, headache Endocrine & metabolic: Hyperglycemia, hypertriglyceridemia Gastrointestinal: Diarrhea Neuromuscular & skeletal: Back pain, CPK increased Renal: Hematuria Respiratory: Bronchitis, pharyngitis, rhinitis, sinusitis Miscellaneous: Flu-like syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 孕期建議   | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

